COMMUNIQUÉS West-GlobeNewswire
-
NOMAD Power Solutions Strengthens Subsidiary Executive Leadership
15/07/2026 -
Lark Health Partners with Samsung to Bring AI-Powered Health Coach to U.S. Seniors
15/07/2026 -
Slate Medicines Strengthens Board of Directors with Appointment of Mark W. Hahn
15/07/2026 -
Cannara Reports Record Q3 Revenues and Continued Profitability Accompanied By Expanding National Distribution and Accelerated Capacity Expansion
15/07/2026 -
SBC Medical to Participate in the “Health, Wellness & Longevity” Virtual Conference Presented by Maxim Group LLC on Wednesday, July 22nd at 10:30 a.m. ET
15/07/2026 -
Belite Bio to Participate in the H.C. Wainwright 6th Annual Ophthalmology Virtual Conference
15/07/2026 -
Alembic Therapeutics LLC Announces Exclusive U.S. Distribution of NUVESSA® (metronidazole vaginal gel 1.3%)
15/07/2026 -
iTonic Holdings Ltd Issues an Update on its Effort to Develop AI-Powered Cloud Healthcare Platform Designed to Support Nuclear Medicine Treatment Planning and with Potential Future Expansion into Digital Care Delivery
15/07/2026 -
ENvue Medical Appoints Chairman of the Board and New Directors, Bringing Clinical, AI Governance and Capital Markets Expertise to Navigation Platform
15/07/2026 -
Rani Therapeutics Announces Positive Initial Phase 1a Data for RT-114 for the Treatment of Obesity, with Oral Bioavailability Exceeding Matched Subcutaneous Dosing
15/07/2026 -
Tonix Pharmaceuticals Announces Publication in the Peer-Reviewed Journal of Virology Assessing Virulence of the 2022 Outbreak Strain of Mpox in New Animal Models
15/07/2026 -
Mixie Technologies, Inc. (OTC: MIXE) Completes Corporate Rebranding and Trading Symbol Change
15/07/2026 -
Cardiff Oncology Announces $10 Million Registered Direct Offering
15/07/2026 -
Cannara annonce un chiffre d’affaires record au troisième trimestre et une rentabilité soutenue, parallèlement à l’extension de sa distribution nationale et à l’accélération de l’augmentation de ses capacités
15/07/2026 -
SciSparc: NeuroThera Labs Announces Initiation of Phase IIb Clinical Trial at Hannover Medical School in Germany for Innovative Treatment of Tourette Syndrome
15/07/2026 -
Cynet Releases v4.33 Unveiling a New Cross-Site Dashboard and Enhanced SIEM Capabilities
15/07/2026 -
UroGen Receives New U.S. Patent Allowance Expected to Provide Protection into July 2044 for ZUSDURI™ and UGN-103
15/07/2026 -
VTAK Announces Preliminary Second Quarter Record Revenue in Excess of $1 million
15/07/2026 -
Genmab Announces Net Sales of DARZALEX® (daratumumab) for Second Quarter of 2026
15/07/2026
Pages